Multiparametric Modelling of Survival in Pancreatic Ductal Adenocarcinoma Using Clinical, Histomorphological, Genetic and Image-Derived Parameters

Rationale: Pancreatic ductal adenocarcinoma (PDAC) remains a tumor entity of exceptionally poor prognosis, and several biomarkers are under current investigation for the prediction of patient prognosis. Many studies focus on promoting newly developed imaging biomarkers without a rigorous comparison...

Full description

Bibliographic Details
Main Authors: Georgios A. Kaissis, Friederike Jungmann, Sebastian Ziegelmayer, Fabian K. Lohöfer, Felix N. Harder, Anna Melissa Schlitter, Alexander Muckenhuber, Katja Steiger, Rebekka Schirren, Helmut Friess, Roland Schmid, Wilko Weichert, Marcus R. Makowski, Rickmer F. Braren
Format: Article
Language:English
Published: MDPI AG 2020-04-01
Series:Journal of Clinical Medicine
Subjects:
Online Access:https://www.mdpi.com/2077-0383/9/5/1250
id doaj-708a3dff742e45ecbfb86f26b825ff78
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Georgios A. Kaissis
Friederike Jungmann
Sebastian Ziegelmayer
Fabian K. Lohöfer
Felix N. Harder
Anna Melissa Schlitter
Alexander Muckenhuber
Katja Steiger
Rebekka Schirren
Helmut Friess
Roland Schmid
Wilko Weichert
Marcus R. Makowski
Rickmer F. Braren
spellingShingle Georgios A. Kaissis
Friederike Jungmann
Sebastian Ziegelmayer
Fabian K. Lohöfer
Felix N. Harder
Anna Melissa Schlitter
Alexander Muckenhuber
Katja Steiger
Rebekka Schirren
Helmut Friess
Roland Schmid
Wilko Weichert
Marcus R. Makowski
Rickmer F. Braren
Multiparametric Modelling of Survival in Pancreatic Ductal Adenocarcinoma Using Clinical, Histomorphological, Genetic and Image-Derived Parameters
Journal of Clinical Medicine
pancreatic ductal adenocarcinoma
survival analysis
multiparametric modelling
genetics
molecular phenotyping
image-derived features
author_facet Georgios A. Kaissis
Friederike Jungmann
Sebastian Ziegelmayer
Fabian K. Lohöfer
Felix N. Harder
Anna Melissa Schlitter
Alexander Muckenhuber
Katja Steiger
Rebekka Schirren
Helmut Friess
Roland Schmid
Wilko Weichert
Marcus R. Makowski
Rickmer F. Braren
author_sort Georgios A. Kaissis
title Multiparametric Modelling of Survival in Pancreatic Ductal Adenocarcinoma Using Clinical, Histomorphological, Genetic and Image-Derived Parameters
title_short Multiparametric Modelling of Survival in Pancreatic Ductal Adenocarcinoma Using Clinical, Histomorphological, Genetic and Image-Derived Parameters
title_full Multiparametric Modelling of Survival in Pancreatic Ductal Adenocarcinoma Using Clinical, Histomorphological, Genetic and Image-Derived Parameters
title_fullStr Multiparametric Modelling of Survival in Pancreatic Ductal Adenocarcinoma Using Clinical, Histomorphological, Genetic and Image-Derived Parameters
title_full_unstemmed Multiparametric Modelling of Survival in Pancreatic Ductal Adenocarcinoma Using Clinical, Histomorphological, Genetic and Image-Derived Parameters
title_sort multiparametric modelling of survival in pancreatic ductal adenocarcinoma using clinical, histomorphological, genetic and image-derived parameters
publisher MDPI AG
series Journal of Clinical Medicine
issn 2077-0383
publishDate 2020-04-01
description Rationale: Pancreatic ductal adenocarcinoma (PDAC) remains a tumor entity of exceptionally poor prognosis, and several biomarkers are under current investigation for the prediction of patient prognosis. Many studies focus on promoting newly developed imaging biomarkers without a rigorous comparison to other established parameters. To assess the true value and leverage the potential of all efforts in this field, a multi-parametric evaluation of the available biomarkers for PDAC survival prediction is warranted. Here we present a multiparametric analysis to assess the predictive value of established parameters and the added contribution of newly developed imaging features such as biomarkers for overall PDAC patient survival. Methods: 103 patients with resectable PDAC were retrospectively enrolled. Clinical and histopathological data (age, sex, chemotherapy regimens, tumor size, lymph node status, grading and resection status), morpho-molecular and genetic data (tumor morphology, molecular subtype, tp53, kras, smad4 and p16 genetics), image-derived features and the combination of all parameters were tested for their prognostic strength based on the concordance index (CI) of multivariate Cox proportional hazards survival modelling after unsupervised machine learning preprocessing. Results: The average CIs of the out-of-sample data were: 0.63 for the clinical and histopathological features, 0.53 for the morpho-molecular and genetic features, 0.65 for the imaging features and 0.65 for the combined model including all parameters. Conclusions: Imaging-derived features represent an independent survival predictor in PDAC and enable the multiparametric, machine learning-assisted modelling of postoperative overall survival with a high performance compared to clinical and morpho-molecular/genetic parameters. We propose that future studies systematically include imaging-derived features to benchmark their additive value when evaluating biomarker-based model performance.
topic pancreatic ductal adenocarcinoma
survival analysis
multiparametric modelling
genetics
molecular phenotyping
image-derived features
url https://www.mdpi.com/2077-0383/9/5/1250
work_keys_str_mv AT georgiosakaissis multiparametricmodellingofsurvivalinpancreaticductaladenocarcinomausingclinicalhistomorphologicalgeneticandimagederivedparameters
AT friederikejungmann multiparametricmodellingofsurvivalinpancreaticductaladenocarcinomausingclinicalhistomorphologicalgeneticandimagederivedparameters
AT sebastianziegelmayer multiparametricmodellingofsurvivalinpancreaticductaladenocarcinomausingclinicalhistomorphologicalgeneticandimagederivedparameters
AT fabianklohofer multiparametricmodellingofsurvivalinpancreaticductaladenocarcinomausingclinicalhistomorphologicalgeneticandimagederivedparameters
AT felixnharder multiparametricmodellingofsurvivalinpancreaticductaladenocarcinomausingclinicalhistomorphologicalgeneticandimagederivedparameters
AT annamelissaschlitter multiparametricmodellingofsurvivalinpancreaticductaladenocarcinomausingclinicalhistomorphologicalgeneticandimagederivedparameters
AT alexandermuckenhuber multiparametricmodellingofsurvivalinpancreaticductaladenocarcinomausingclinicalhistomorphologicalgeneticandimagederivedparameters
AT katjasteiger multiparametricmodellingofsurvivalinpancreaticductaladenocarcinomausingclinicalhistomorphologicalgeneticandimagederivedparameters
AT rebekkaschirren multiparametricmodellingofsurvivalinpancreaticductaladenocarcinomausingclinicalhistomorphologicalgeneticandimagederivedparameters
AT helmutfriess multiparametricmodellingofsurvivalinpancreaticductaladenocarcinomausingclinicalhistomorphologicalgeneticandimagederivedparameters
AT rolandschmid multiparametricmodellingofsurvivalinpancreaticductaladenocarcinomausingclinicalhistomorphologicalgeneticandimagederivedparameters
AT wilkoweichert multiparametricmodellingofsurvivalinpancreaticductaladenocarcinomausingclinicalhistomorphologicalgeneticandimagederivedparameters
AT marcusrmakowski multiparametricmodellingofsurvivalinpancreaticductaladenocarcinomausingclinicalhistomorphologicalgeneticandimagederivedparameters
AT rickmerfbraren multiparametricmodellingofsurvivalinpancreaticductaladenocarcinomausingclinicalhistomorphologicalgeneticandimagederivedparameters
_version_ 1724645182861737984
spelling doaj-708a3dff742e45ecbfb86f26b825ff782020-11-25T03:14:01ZengMDPI AGJournal of Clinical Medicine2077-03832020-04-0191250125010.3390/jcm9051250Multiparametric Modelling of Survival in Pancreatic Ductal Adenocarcinoma Using Clinical, Histomorphological, Genetic and Image-Derived ParametersGeorgios A. Kaissis0Friederike Jungmann1Sebastian Ziegelmayer2Fabian K. Lohöfer3Felix N. Harder4Anna Melissa Schlitter5Alexander Muckenhuber6Katja Steiger7Rebekka Schirren8Helmut Friess9Roland Schmid10Wilko Weichert11Marcus R. Makowski12Rickmer F. Braren13Department of Diagnostic and Interventional Radiology, School of Medicine, Technical University of Munich, 81675 Munich, GermanyDepartment of Diagnostic and Interventional Radiology, School of Medicine, Technical University of Munich, 81675 Munich, GermanyDepartment of Diagnostic and Interventional Radiology, School of Medicine, Technical University of Munich, 81675 Munich, GermanyDepartment of Diagnostic and Interventional Radiology, School of Medicine, Technical University of Munich, 81675 Munich, GermanyDepartment of Diagnostic and Interventional Radiology, School of Medicine, Technical University of Munich, 81675 Munich, GermanyInstitute for Pathology, School of Medicine, Technical University of Munich, 81675 Munich, GermanyInstitute for Pathology, School of Medicine, Technical University of Munich, 81675 Munich, GermanyInstitute for Pathology, School of Medicine, Technical University of Munich, 81675 Munich, GermanySchool of Medicine, Surgical Clinic and Policlinic, Technical University of Munich, 81675 Munich, GermanySchool of Medicine, Surgical Clinic and Policlinic, Technical University of Munich, 81675 Munich, GermanyDepartment of Internal Medicine II, School of Medicine, Technical University of Munich, 81675 Munich, GermanyInstitute for Pathology, School of Medicine, Technical University of Munich, 81675 Munich, GermanyDepartment of Diagnostic and Interventional Radiology, School of Medicine, Technical University of Munich, 81675 Munich, GermanyDepartment of Diagnostic and Interventional Radiology, School of Medicine, Technical University of Munich, 81675 Munich, GermanyRationale: Pancreatic ductal adenocarcinoma (PDAC) remains a tumor entity of exceptionally poor prognosis, and several biomarkers are under current investigation for the prediction of patient prognosis. Many studies focus on promoting newly developed imaging biomarkers without a rigorous comparison to other established parameters. To assess the true value and leverage the potential of all efforts in this field, a multi-parametric evaluation of the available biomarkers for PDAC survival prediction is warranted. Here we present a multiparametric analysis to assess the predictive value of established parameters and the added contribution of newly developed imaging features such as biomarkers for overall PDAC patient survival. Methods: 103 patients with resectable PDAC were retrospectively enrolled. Clinical and histopathological data (age, sex, chemotherapy regimens, tumor size, lymph node status, grading and resection status), morpho-molecular and genetic data (tumor morphology, molecular subtype, tp53, kras, smad4 and p16 genetics), image-derived features and the combination of all parameters were tested for their prognostic strength based on the concordance index (CI) of multivariate Cox proportional hazards survival modelling after unsupervised machine learning preprocessing. Results: The average CIs of the out-of-sample data were: 0.63 for the clinical and histopathological features, 0.53 for the morpho-molecular and genetic features, 0.65 for the imaging features and 0.65 for the combined model including all parameters. Conclusions: Imaging-derived features represent an independent survival predictor in PDAC and enable the multiparametric, machine learning-assisted modelling of postoperative overall survival with a high performance compared to clinical and morpho-molecular/genetic parameters. We propose that future studies systematically include imaging-derived features to benchmark their additive value when evaluating biomarker-based model performance.https://www.mdpi.com/2077-0383/9/5/1250pancreatic ductal adenocarcinomasurvival analysismultiparametric modellinggeneticsmolecular phenotypingimage-derived features